Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of June 8, 2020.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of June 4, 2020.
Sales revenues for May 2020
Sofia, Bulgaria, June 5, 2020 – “Sopharma” AD notifies that for May 2020 the Company recorded a decrease in sales of 6% compared to the same month of 2019, incl. 9% decrease in domestic sales and 5% decrease in export sales.
In the first five months of 2020 the revenues from sales of production increase by 2% compared to the same period of 2019, incl. a decrease with 4% of sales for the domestic market and 6% increase in export sales.
Notification on the terms and conditions for distribution of the dividend
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of June 3, 2020.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of June 3, 2020.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of June 2, 2020.
Notification from Donev Investments Holding AD under Art. 19 of Regulation (EU) No 596/2014 of June 1, 2020
Notification for acquisition of own shares
Sofia, Bulgaria, June 2, 2020 – “Sopharma” AD notifies that on June 1, 2020 the Company bought 86 748 own shares representing 0.0644% of the share capital of the Company, at a total value of 260 244 BGN on the Bulgarian Stock Exchange, the average price per share was 3.00 BGN.
The total number of treasury shares after this transaction is 9 200 215 representing 6.83% of the share capital of the Company.